Home » Topics » BioWorld Science

BioWorld Science
RSS

Neuropathy may unify disparate long COVID symptoms

March 2, 2022

HuR ablation ameliorates allergen-induced asthmatic symptoms

March 2, 2022

LIGHT mediates esophageal remodeling in murine model of eosinophilic esophagitis

March 2, 2022

Quanterix collaborates with Lilly on diagnosis and treatment of Alzheimer's disease

March 2, 2022

JAK1 activation of sensory neurons suppresses lung inflammation

March 2, 2022

HLA-DPB1*05:01 allele predicts nonresponse to SLIT in allergic rhinitis

March 2, 2022

SIGLEC-6 targeting inhibits human mast cell degranulation and anaphylaxis

March 2, 2022

Bayer, Deutsches Krebsforschungszentrum patent aryl hydrocarbon receptor antagonists

March 2, 2022

Complement factor B inhibitors discovered at Shanghai Meiyue Biotech Development

March 2, 2022

Spexis, University of Zurich describe new antimicrobial peptidomimetics

March 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...